No Data
A-share unusual movement | zhejiang shapuaisi pharmaceutical rose more than 7%, Q3 revenue increased by 23.77% compared to the previous quarter.
Gelonghui on October 31 | zhejiang shapuaisi pharmaceutical (603168.SH) rose more than 7% to 8.5 yuan, with a total market value of 3.2 billion yuan. The company's revenue in the first three quarters was 359.402 million yuan. Among them, the revenue in the third quarter was 122.5498 million yuan, an increase of 23.77% compared to the previous quarter; net income attributable to the parent company was -6.0384 million yuan, narrowing the loss compared to the previous quarter. The company continues to increase its investment in research and development, actively promoting the research and development of new products, and transforming research and development into a driving force for high-quality development. (Gelonghui)
Sharp Ace: Sharp Ace Report for the Third Quarter of 2024
Sharp Ace 2024 Third Quarter Report
Zhejiang Shapuaisi Pharmaceutical (603168.SH) released its performance for the first three quarters, with a net loss of 30.76 million yuan.
Zhejiang Shapuaisi Pharmaceutical (603168.SH) disclosed its third quarter report for 2024, achieving a revenue of 3....
zhejiang shapuaisi pharmaceutical (603168.SH): net loss of 30.7554 million yuan in the first three quarters.
Gelonghui October 30th | Zhejiang Shapuaisi Pharmaceutical (603168.SH) announced that in the first three quarters of 2024, it achieved revenue of 0.359 billion yuan, a decrease of 27.95% year-on-year; net income attributable to shareholders of the listed company was -30.7554 million yuan, basic earnings per share was -0.08 yuan.
A-share infants-related concept stocks rise, shanghai aiyingshi hits the limit up.
Gelonghui on October 22nd | Shanghai Aiyingshi, Zhejiang Shapuaisi pharmaceutical hit the limit up, Child King up nearly 10%, Beingmate Co., Ltd, Jinhong Fashion Group, Hailun Piano, Ningbo David Medical Device, etc. followed the uptrend. On the news front, Chongqing Medical Insurance Bureau recently issued a notice on the price items of assisted reproduction medical services and medical insurance payment policies, clearly stating that starting from January 1st next year, 13 therapeutic assisted reproduction medical service items such as sperm preselection processing, ovum retrieval, etc. will be included in the scope of basic medical insurance payment in the city. Prior to this, more than 20 provinces nationwide have included assisted reproduction in medical insurance.
No Data
No Data